Tempest Therapeutics (TPST) Insider Trading & Ownership $0.94 +0.03 (+3.30%) (As of 11/26/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tempest Therapeutics (NASDAQ:TPST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$100,001.36Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$966,798.90 Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TPST Insider Buying and Selling by Quarter Ad Genesis Gold GroupWarren Buffett Is Sitting on $278 Billion in Cash—Should You Be Worried?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Tempest Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/12/2024Versant Venture Capital Vi, L.Major ShareholderSell387,999$1.10$426,798.90 8/8/2024Versant Venture Capital Vi, L.Major ShareholderSell400,000$1.35$540,000.00 7/3/2024Stephen R BradyCEOBuy35,000$2.11$73,850.00 7/2/2024Samuel WhitingInsiderBuy4,672$2.13$9,951.36 6/28/2024Justin TrojanowskiInsiderBuy7,500$2.16$16,200.00 (Data available from 1/1/2013 forward) TPST Insider Trading Activity - Frequently Asked Questions Who is on Tempest Therapeutics's Insider Roster? The list of insiders at Tempest Therapeutics includes Justin Trojanowski, Samuel Whiting, Stephen R Brady, Thomas W Dubensky, Thomas Woiwode, and Versant Venture Capital Vi, L.. Learn more on insiders at TPST. What percentage of Tempest Therapeutics stock is owned by insiders? 4.70% of Tempest Therapeutics stock is owned by insiders. Learn more on TPST's insider holdings. Which Tempest Therapeutics insiders have been buying company stock? The following insiders have purchased TPST shares in the last 24 months: Justin Trojanowski ($16,200.00), Samuel Whiting ($9,951.36), and Stephen R Brady ($73,850.00). How much insider buying is happening at Tempest Therapeutics? Insiders have purchased a total of 47,172 TPST shares in the last 24 months for a total of $100,001.36 bought. Which Tempest Therapeutics insiders have been selling company stock? The following insider sold TPST shares in the last 24 months: Versant Venture Capital Vi, L. ($966,798.90). How much insider selling is happening at Tempest Therapeutics? Insiders have sold a total of 787,999 Tempest Therapeutics shares in the last 24 months for a total of $966,798.90 sold. Tempest Therapeutics Key ExecutivesMr. Stephen R. Brady J.D. (Age 54)LLM, CEO, President & Director Compensation: $923.24k1 recent tradesMr. Nicholas Maestas (Age 43)VP of Strategy & Finance and Secretary Compensation: $465.43kDr. Samuel Whiting M.D. (Age 58)Ph.D., Executive VP & Chief Medical Officer Compensation: $667.65kMr. Justin Trojanowski (Age 36)Corporate Controller, Treasurer & Principal Accounting Officer 1 recent tradesMs. Lindsay YoungHead of Human ResourcesDr. Sharon Sakai Ph.D.RAC, Head of Regulatory & Quality More Insider Trading Tools from MarketBeat Related Companies CADL Insider Trades GOSS Insider Trades DRUG Insider Trades SGMT Insider Trades HURA Insider Trades FTLF Insider Trades MCRB Insider Trades CHRS Insider Trades PBYI Insider Trades BDTX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:TPST) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe Great AI-Energy CollisionThe biggest players in AI and tech are desperate to bring this limitless power source online. And fast. It...Porter & Company | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.